Science Says: Addiction Is a Chronic Disease, Not a Moral Failing

Understanding the brain’s role in addiction can help break the stigma surrounding the illness — and encourage individuals to seek help.

7:00 AM

Author | Jillian Hardee, Ph.D.

Addiction is a serious issue: The U.S. is currently facing an opioid epidemic, and excessive use of alcohol continues to be one of the leading preventable causes of death, according to the Centers for Disease Control and Prevention.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

In a November 2016 report, former Surgeon General Vivek Murthy, M.D., publicly confirmed what researchers have known for years: Addiction is a chronic illness accompanied by significant changes in the brain.

Addiction does not occur because of moral weakness, a lack of willpower or an unwillingness to stop. This finding stems from decades of work investigating the effects of substance use on the brain.

The first time individuals drink or take drugs, they do so voluntarily, and they believe they can control their use. With time, more and more alcohol or drugs are needed to achieve the same level of pleasure and satisfaction as when they first started. Seeking out and taking the substance becomes a near-constant activity, causing significant problems for them and their family and friends. At the same time, progressive changes in the brain drive the compulsive, uncontrollable drug use known as addiction.

When this happens, individuals can no longer voluntarily choose to not use drugs or alcohol, even if it means losing everything they once valued.

Addiction does not occur because of moral weakness, a lack of willpower or an unwillingness to stop.
Jillian Hardee, Ph.D.

The brain on addiction

Research has identified a number of areas in the brain key to the development and persistence of addiction. In particular, pathways containing dopamine are where many drugs exert their effects. Dopamine is a small chemical in the brain important for carrying signals from one brain cell to the next, similar to how a train carries cargo between stations. Pathways where dopamine is present are involved in many different functions, one of which is reward-motivated behavior.

In the healthy brain, dopamine is released in response to natural rewards, such as food or exercise, as a way of saying, "that was good." But drugs hijack dopamine pathways, teaching the brain that drugs are good, too. For example, some drugs have a structure similar to other chemical messengers in the brain, allowing them to bind to brain cells and release dopamine. Therefore, taking a drug produces a euphoric feeling, which in turn strongly reinforces drug-using behavior.

Drugs release two to 10 times the amount of dopamine that natural rewards release. How much is released depends on the type of drug; amphetamines, for example, release more dopamine than cocaine. As a result, the increased and sometimes constant influx of dopamine means feelings of reward, motivation or pleasure are also increased.

But if substance use continues, the brain produces less dopamine and/or reduces the number of brain structures that receive dopamine. Thus, dopamine's impact on the reward network diminishes, along with the individual's ability to experience pleasure.

This explains why individuals who chronically abuse drugs or alcohol begin to appear lethargic, unmotivated and depressed, and report a lack of pleasure in things that were once pleasurable. To counter this, they increase their substance use in an attempt to feel the same pleasure they used to. This only exacerbates the problem, creating a vicious cycle of needing to take the drug in order to regain dopamine levels, then later needing to increase the dose, and so on, an effect known as tolerance.

SEE ALSO: Opioids: When the Harms Outweigh the Benefits

While short-term use may only produce small, transient effects in the brain, prolonged substance use changes the brain in fundamental ways that reinforce continued use, such as the strengthening of memory circuits associated with drug taking. Cues that are social (such as being around substance-using friends), geographic (former favorite bars), and physical (experiencing stress) in nature become strongly associated with the drug. These have a powerful impact on the brain — no matter if that person has been abstinent for 15 days or 15 years — and can trigger a relapse.

Brain changes from chronic drug or alcohol use can persist years after a person quits. This is why individuals risk relapse even after long periods of abstinence, and despite a relapse's potentially devastating effects. More importantly, this is why treatment depends on the type of drug and the individual characteristics of the patient.

Understanding the brain's role in addiction can help reduce negative perceptions and attitudes of those struggling with substance use disorders. Because addiction is typically a chronic disorder characterized by intermittent relapses, a short-term, one-time treatment is generally not sufficient. However, research shows that addiction can be managed successfully. Individuals who enter and remain in treatment can manage their addiction and improve their quality of life.

If you or a loved one is dealing with an addiction, the University of Michigan Addiction Treatment Services (UMATS) offers assessment, diagnosis and treatment personalized for individuals and their families. UMATS accepts a variety of private insurance plans and is here to help. Please call 1-800-525-5188 to schedule an appointment, or visit the Addiction Center online to schedule an appointment.


More Articles About: Brain Health Addiction and Mental Illness Mental Health Addiction and Substance Abuse
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Michigan Medicine Presents... on dark blue background with two lights shining on the words
Michigan Medicine Presents
Episode 3: Medication, Relationships, and Caretaking
Like many other mental health conditions, bipolar disorder is still quite stigmatized in our society. Stigma can play a significant role in how people living with bipolar disorder receive treatment and care, their education and careers, and many other aspects of daily life. For this episode, we’ll be tackling topics like medications, relationships, the workplace, and supporting a loved one. We’ll be hearing from Dr. Sagar Parikh, a psychiatrist in the Michigan Medicine Bipolar Disorder Clinic and professor of psychiatry and of health policy and management in the School of Public Health at UofM, and Michelle Yang, writer, activist, marketing project manager, and research participant with the Heinz C. Prechter Bipolar Research Program.
Michigan Medicine Presents... on dark blue background with two lights shining on the words
Michigan Medicine Presents
Episode 1: The Science of Bipolar Disorder
Bipolar disorder is more than just mood swings. It’s a journey marked by intense highs of mania and debilitating lows of depression. But within this condition exist millions of people who live unique lives. Today, we're going to talk to three clinical and research experts from the Heinz C. Prechter Bipolar Research Program at Michigan Medicine to learn more about the science of bipolar disorder—diagnostics, genetics, and decision-making. We'll be hearing from Dr. Melvin McInnis, director of the Prechter Program, Dr. Paul Jenkins, associate professor of pharmacology and associate director of the Prechter Program, and Dr. Chandra Sripada, professor of psychiatry and philosophy.
Michigan Medicine Presents... on dark blue background with two lights shining on the words
Michigan Medicine Presents
Episode 2: Exploring the Meaning of Wellness
Research into conditions like bipolar disorder cannot happen without the participation of hundreds of people who sign up for research studies and programs like the Heinz C. Prechter Bipolar Research Program. In this episode, we’ll unpack wellness—how we define and measure it healthcare and research settings. We’re joined by Dr. Alexandra Vinson, assistant professor of Learning Health Sciences and co-lead of the Prechter Bipolar Disorder Learning Community. Stephanie Prechter, artist, philanthropist, a bipolar disorder research participant with lived experience and board member of the Prechter Program, and Dr. Sarah Sperry, director of the Emotion and Temporal Dynamics Lab and associate director of the Prechter Program.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
How Can We Achieve Health Equity?
In today's episode of The Fundamentals, we talk with Dr. John Ayanian, director of the U-M Institute for Healthcare Policy and Innovation. Dr. Ayanian's research explores underlying factors that contribute to persistent health disparities between minoritized groups and their white counterparts, as well as strategies for ending inequity in health care and improving overall health outcomes for everyone.
Courtney Burns standing next to the "You Are Not Alone" first aid kit painting by Morgan Graznow.
Department News
Bridging Art and Medicine: Courtney Burns' Transformative RISE Journey
Medical student Courtney Burns uses art to address secondary traumatic stress in anesthesiology, fostering emotional resilience and peer support in medicine.
woman talking to doctor on computer
Health Lab
Telehealth didn’t increase Medicare visits, but drove down post-visit costs
Concerns about telehealth’s potential to lead to more in-person care and higher costs are not panning out, which has implications for extending COVID-era flexibility.